CSF1R and neuroblastoma: A recent study by Mao et al. found that myeloid cells isolated from neuroblastoma tumors express high levels of PDL1, and combining CSF1R inhibition with anti-PD1/PDL1 antibodies lead to better anti-tumor immune response and improved survival in mouse model of neuroblastoma (56).